NASDAQ:NERV - Nasdaq - US6033802058 - Common Stock - Currency: USD
TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 19.07M | 22.00M | 23.12M | 25.23M | 45.37M | |||
Research and Development | 9.09M | N/A | 12.71M | 14.65M | 32.04M | |||
Selling, General, and Administrative Expenses | 9.98M | 9.95M | 10.41M | 10.58M | 13.33M | |||
Operating Income | -19.07M | -22.00M | -23.12M | -25.23M | -45.37M | |||
Interest Income/Expense | 1.06M | N/A | 1.40M | 530.00K | -20.00K | |||
Other Income/Expense | N/A | 22.00M | -8.28M | -7.41M | -6.33M | |||
Income Before Taxes | 6.26M | 1.44M | -30.01M | -32.11M | -51.71M | |||
Income Tax | N/A | N/A | N/A | 0.00 | -1.80M | |||
Net Income | 6.26M | 1.44M | -30.01M | -32.11M | -49.91M | |||
EBITDA | -19.05M | -21.98M | -23.09M | -25.22M | N/A | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | 0.82 | 0.19 | -4.61 | -6.01 | -9.35 | |||
Non GAAP EPS | -2.69 | -3.32 | -4.85 | -6.02 | -9.20 | |||
Statistics | ||||||||
Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
Operating Profit Margin | N/A | N/A | N/A | N/A | N/A |
All data in USD